Literature DB >> 11018730

Fluorescence and nucleic acid binding properties of the human T-cell leukemia virus-type 1 nucleocapsid protein.

D R Morcock1, B P Kane, J R Casas-Finet.   

Abstract

We used intrinsic tryptophan fluorescence to study the nucleocapsid protein from human T-cell leukemia virus-type one, HTLV-1 p15, an 85-amino-acid protein with two Trp-containing zinc-finger motifs. Fluorescence spectra suggested an interaction between the two zinc fingers and another interaction involving the C-terminal tail and the zinc fingers. Titrations with nucleic acid revealed similar, sub-micromolar affinity for poly(dT) and poly(U) in 1 mM sodium phosphate, pH 7. Double-stranded DNA bound an order of magnitude weaker, suggesting helix-destabilizing activity. Base preference of p15 was T approximately U>I approximately C approximately G>A; affinity spanned about one order of magnitude. HTLV-1 p15 bound weaker and with less variation than reported values for either human or simian immunodeficiency virus homologues. The low affinity of p15 for nonspecific nucleic acids distinguishes it from other nucleocapsid proteins, and may suggest its involvement in additional steps of the virus life cycle other than RNA packaging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018730     DOI: 10.1016/s0167-4838(00)00181-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

2.  C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.

Authors:  Dominic F Qualley; Kristen M Stewart-Maynard; Fei Wang; Mithun Mitra; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

3.  Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.

Authors:  David Derse; Shawn A Hill; Gerald Princler; Patricia Lloyd; Gisela Heidecker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

4.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

5.  Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer.

Authors:  Qusai Darugar; Hannah Kim; Robert J Gorelick; Christy Landes
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

6.  Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity.

Authors:  Kristen M Stewart-Maynard; Margareta Cruceanu; Fei Wang; My-Nuong Vo; Robert J Gorelick; Mark C Williams; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

Review 7.  Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly.

Authors:  Erik D Olson; Karin Musier-Forsyth
Journal:  Semin Cell Dev Biol       Date:  2018-04-01       Impact factor: 7.727

8.  Phylogenetic Analysis of South African Bovine Leukaemia Virus (BLV) Isolates.

Authors:  Akiko Suzuki; Rosamund Chapman; Nicola Douglass; Olivia Carulei; Johan van Rensburg; Anna-Lise Williamson
Journal:  Viruses       Date:  2020-08-17       Impact factor: 5.048

Review 9.  Retroviral nucleocapsid proteins and DNA strand transfers.

Authors:  Brigitte René; Olivier Mauffret; Philippe Fossé
Journal:  Biochim Open       Date:  2018-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.